Jubilant Pharmova Limited (NSE: JUBLPHARMA) reported a Revenue from Operations of ₹1,533.22 Crores, a boost of 18% growth from the previous year. The Net Loss for the business is ₹16.04 Crore from the profit of ₹50.80 Crore year on year. Earnings per Share is -₹0.98 for this quarter.
Jubilant Pharmova Limited Q3 FY23; Revenue Increased By 18%
Tags: pharmaceuticals
Related Post
- Firstsource Solutions Q2 FY26 Earnings Results
Firstsource Solutions Ltd, a leading player in Business Process Management (BPM) and part of the…
-
Foseco India Q2 FY26 Earnings Results
Foseco India Ltd, incorporated in 1958 and engaged in manufacturing metallurgical additives and consumables that…
-
Force Motors Q2 FY26 Earnings Results
Force Motors Ltd, founded in 1958 and part of the Abhay Firodia Group, specializes in…